Search Results - "Igor, Andrašina"

Alcoholic Liver Disease-Related Hepatocellular Carcinoma: Characteristics and Comparison to General Slovak Hepatocellular Cancer Population by Šafčák, Dominik, Dražilová, Sylvia, Gazda, Jakub, Andrašina, Igor, Adamcová-Selčanová, Svetlana, Barila, Radovan, Mego, Michal, Rác, Marek, Skladaný, Ľubomír, Žigrai, Miroslav, Janičko, Martin, Jarčuška, Peter

“…Hepatocellular carcinoma (HCC) has multiple molecular classes that are associated with distinct etiologies and, besides particular molecular characteristics,…”
Get full text

Systemic treatment for hepatocellular carcinoma by Ján, Tokarčík, Dáša, Slížová, Igor, Andrašina, Jana, Vaculová

“…Hepatocellular carcinoma (HCC) is one of the most common types of cancer with increasing incidence. It accounts for approximately 90% of primary liver cancers…”
Get more information

Enhancement of docetaxel-treated MCF-7 cell death by 900-MHz radiation by Trebuňová Marianna, Laputková Galina, Géci Imrich, Andrašina Igor, Sabo Ján

Get full text

Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: Clinical Patterns, Outcomes, and Prognostic Factors for Overall Survival—A Retrospective Analysis of a Slovak Cohort by Safcak, Dominik, Drazilova, Sylvia, Gazda, Jakub, Andrasina, Igor, Adamcova-Selcanova, Svetlana, Barila, Radovan, Mego, Michal, Rac, Marek, Skladany, Lubomir, Zigrai, Miroslav, Janicko, Martin, Jarcuska, Peter

“…Objective: To compare NAFLD-related HCC and other etiology-related HCC and to describe predictive factors for survival in patients with NAFLD-related HCC…”
Get full text

Autologous dendritic cell-based immunotherapy (DCVAC/LuCa) and carboplatin/paclitaxel in advanced non-small cell lung cancer: A randomized, open-label, phase I/II trial by Zemanova, Milada, Cernovska, Marketa, Havel, Libor, Bartek, Tomas, Lukesova, Sarka, Jakesova, Jitka, Vanasek, Jaroslav, Reiterer, Pavel, Kultan, Juraj, Andrasina, Igor, Siskova, Lenka, Koubkova, Leona, Skrickova, Jana, Salajka, Frantisek, Pesek, Milos, Klepetko, Petr, Beniak, Juraj, Fricke, Harald, Kadlecova, Pavla, Korolkiewicz, Roman P., Hraska, Marek, Bartunkova, Jirina, Spisek, Radek

“…•Dendritic cell-based immunotherapy (DCVAC/LuCa) plus a platinum doublet in NSCLC.•SLU01: a multicenter, open-label, parallel-group, randomized, phase I/II…”
Get full text

Osimertinib with or without Chemotherapy in EGFR -Mutated Advanced NSCLC by Planchard, David, Jänne, Pasi A, Cheng, Ying, Yang, James C-H, Yanagitani, Noriko, Kim, Sang-We, Sugawara, Shunichi, Yu, Yan, Fan, Yun, Geater, Sarayut L, Laktionov, Konstantin, Lee, Chee K, Valdiviezo, Natalia, Ahmed, Samreen, Maurel, Jean-Marc, Andrasina, Igor, Goldman, Jonathan, Ghiorghiu, Dana, Rukazenkov, Yuri, Todd, Alex, Kobayashi, Kunihiko

“…Osimertinib is a third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) that is selective for EGFR-TKI-sensitizing and T790M…”
Get full text

Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line by Bober, Peter, Alexovic, Michal, Talian, Ivan, Tomkova, Zuzana, Viscorova, Zuzana, Benckova, Maria, Andrasina, Igor, Ciccocioppo, Rachele, Petrovic, Daniel, Adamek, Mariusz, Kruzliak, Peter, Sabo, Jan

“…Purpose Doxorubicin is an anthracycline drug which inhibits the growth of breast cancer cell lines. However, a major factor limiting its use is a cumulative,…”
Get full text

Inflammatory Indexes as Prognostic Factors of Survival in Geriatric Patients with Hepatocellular Carcinoma: A Case Control Study of Eight Slovak Centers by Safcak, Dominik, Drazilova, Sylvia, Gazda, Jakub, Andrasina, Igor, Adamcova-Selcanova, Svetlana, Balazova, Lea, Barila, Radovan, Mego, Michal, Rac, Marek, Skladany, Lubomir, Zigrai, Miroslav, Janicko, Martin, Jarcuska, Peter

“…Background and Aims: Hepatocellular cancer (HCC) often occurs in geriatric patients. The aim of our study was to compare overall survival and progression-free…”
Get full text

P15. Crizotinib in metastatic ALK-positive lung cancer—results from clinical practice in Slovakia by Berzinec, Peter, Kasan, Peter, Plank, Lukas, Andrasina, Igor, Godal, Robert, Mazal, Juraj, Cipkova, Andrea, Denkova, Lucia, Chowaniecova, Gabriela, Kuliskova, Iveta

Get full text

40 Adjuvant chemotherapy inoperable non-small cell lung cancer (NSCLC). Our treatment results by Baumohl, Juraj, Andrasˇina, Igor, Wagnerova, Maria, Janík, Miroslav

Get full text